Skip to main content

Table 2 Psychiatric disorders in the patients’ group by SCID-I and SCID-II scales

From: Synthetic cannabinoids impact on cognitive functions

SCID-I and SCID-II scales

SC n (%)

Schizophrenia

9 (30%)

Bipolar affective disorder

7 (23.3%)

Major Depressive disorder

1 (3.3%)

Antisocial personality disorder

19 (63.3%)

Borderline personality disorder

27 (90%)

  1. SC, synthetic cannabinoids